
Quarterly Result10 Feb 2026, 06:12 pm
JHS Svendgaard Laboratories Ltd. Reports No Deviation in Utilization of Funds for Q4 2025
AI Summary
JHS Svendgaard Laboratories Ltd. has reported no deviation in the utilization of funds raised through a preferential issue, as per the Statement of Deviation or Variation for the quarter ended December 31, 2025. The company raised Rs. 29.99 crores on June 4, 2024, for setting up a new project in Jammu & Kashmir and for general corporate purposes. The company also infused funds into its group entity, JHS Svendgaard Retail Ventures Ltd., for funding the expansion plan. All these allocations and utilizations are as per the approved objects.
Key Highlights
- JHS Svendgaard Laboratories Ltd. reported no deviation in utilization of funds for Q4 2025
- Raised Rs. 29.99 crores on June 4, 2024, for setting up a new project in Jammu & Kashmir and for general corporate purposes
- Infused funds into JHS Svendgaard Retail Ventures Ltd. for funding the expansion plan
- All allocations and utilizations are as per the approved objects
- No deviation or variation in the utilization of funds
Price Impact
More from JHS